Aquatic Capital Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-229,939
Closed -$23.4M 1503
2025
Q4
$23.4M Buy
229,939
+35,666
+18% +$2.86M 0.66% 26
2025
Q3
$10.6M Buy
194,273
+132,331
+214% +$6.61M 0.2% 128
2025
Q2
$3.29M Buy
61,942
+41,617
+205% +$2.11M 0.07% 341
2025
Q1
$880K Buy
+20,325
New +$1.03M 0.02% 633
2024
Q3
Sell
-64,400
Closed -$2.72M 1253
2024
Q2
$2.72M Buy
+64,400
New +$3.54M 0.1% 202
2024
Q1
Sell
-18,600
Closed -$1.38M 1345
2023
Q4
$1.38M Buy
18,600
+12,000
+182% +$787K 0.04% 418
2023
Q3
$450K Buy
+6,600
New +$560K 0.02% 507
2022
Q4
Sell
-43,900
Closed -$1.43M 1503
2022
Q3
$1.43M Buy
43,900
+34,700
+377% +$1.43M 0.14% 202
2022
Q2
$362K Buy
+9,200
New +$492K 0.12% 213

Other funds holding EXAS

Aquatic Capital Management's EXAS Position: Q1 2026 in Review

Aquatic Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 229,939 shares — an estimated $23.4M sold.

Aquatic Capital Management first reported a position in EXAS in Q2 2022 and held it in 9 quarters. The position peaked at $23.4M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Aquatic Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 229,939 Exact Sciences shares in Q1 2026, an estimated $23.4M.
  • Aquatic Capital Management first reported a position in Exact Sciences in Q2 2022 and held it in 9 quarters.
  • Aquatic Capital Management's Exact Sciences position peaked at $23.4M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.